66 related articles for article (PubMed ID: 17353777)
1. Sparing effect by montelukast treatment for chronic graft versus host disease: a pilot study.
Or R; Gesundheit B; Resnick I; Bitan M; Avraham A; Avgil M; Sacks Z; Shapira MY
Transplantation; 2007 Mar; 83(5):577-81. PubMed ID: 17353777
[TBL] [Abstract][Full Text] [Related]
2. Classification systems for chronic graft-versus-host disease.
Lee SJ
Blood; 2017 Jan; 129(1):30-37. PubMed ID: 27821503
[TBL] [Abstract][Full Text] [Related]
3. Rapid versus gradual lung function decline in bronchiolitis obliterans syndrome after haematopoietic stem cell transplantation is associated with survival outcome.
Kwok WC; Liang BM; Lui MMS; Tam TCC; Sim JPY; Tse EWC; Leung AYH; Kwong YL; Lie AKW; Ip MSM; Lam DCL
Respirology; 2019 May; 24(5):459-466. PubMed ID: 30663178
[TBL] [Abstract][Full Text] [Related]
4. A review of the therapeutic potential of the cysteinyl leukotriene antagonist Montelukast in the treatment of bronchiolitis obliterans syndrome following lung and hematopoietic-stem cell transplantation and its possible mechanisms.
Kordjazy N; Amini S
Ther Adv Respir Dis; 2024; 18():17534666241232284. PubMed ID: 38504551
[TBL] [Abstract][Full Text] [Related]
5. Inhaled Bronchodilators and Corticosteroids in the Management of Bronchiolitis Obliterans due to Allogenic Hematopoietic Stem Cell Transplantation.
Georgakopoulou VE; Gkoufa A; Garmpis N; Garmpi A; Damaskos C
Oman Med J; 2022 May; 37(3):e388. PubMed ID: 35651501
[No Abstract] [Full Text] [Related]
6. Prospective Phase II Trial of Montelukast to Treat Bronchiolitis Obliterans Syndrome after Hematopoietic Cell Transplantation and Investigation into Bronchiolitis Obliterans Syndrome Pathogenesis.
Williams KM; Pavletic SZ; Lee SJ; Martin PJ; Farthing DE; Hakim FT; Rose J; Manning-Geist BL; Gea-Banacloche JC; Comis LE; Cowen EW; Justus DG; Baird K; Cheng GS; Avila D; Steinberg SM; Mitchell SA; Gress RE
Transplant Cell Ther; 2022 May; 28(5):264.e1-264.e9. PubMed ID: 35114411
[TBL] [Abstract][Full Text] [Related]
7. Noninfectious pulmonary complications of haematopoietic stem cell transplantation.
Haider S; Durairajan N; Soubani AO
Eur Respir Rev; 2020 Jun; 29(156):. PubMed ID: 32581138
[TBL] [Abstract][Full Text] [Related]
8. A Preliminary Investigation towards the Risk Stratification of Allogeneic Stem Cell Recipients with Respect to the Potential for Development of GVHD via Their Pre-Transplant Plasma Lipid and Metabolic Signature.
Contaifer D; Roberts CH; Kumar NG; Natarajan R; Fisher BJ; Leslie K; Reed J; Toor AA; Wijesinghe DS
Cancers (Basel); 2019 Jul; 11(8):. PubMed ID: 31349646
[TBL] [Abstract][Full Text] [Related]
9. Montelukast for bronchiolitis obliterans syndrome after lung transplantation: A randomized controlled trial.
Ruttens D; Verleden SE; Demeyer H; Van Raemdonck DE; Yserbyt J; Dupont LJ; Vanaudenaerde BM; Vos R; Verleden GM
PLoS One; 2018; 13(4):e0193564. PubMed ID: 29624575
[TBL] [Abstract][Full Text] [Related]
10. Prevention of chronic rejection after lung transplantation.
Van Herck A; Verleden SE; Vanaudenaerde BM; Verleden GM; Vos R
J Thorac Dis; 2017 Dec; 9(12):5472-5488. PubMed ID: 29312757
[TBL] [Abstract][Full Text] [Related]
11. How I treat bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation.
Williams KM
Blood; 2017 Jan; 129(4):448-455. PubMed ID: 27856461
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic effect of budesonide/formoterol, montelukast and N-acetylcysteine for bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation.
Kim SW; Rhee CK; Kim YJ; Lee S; Kim HJ; Lee JW
Respir Res; 2016 May; 17(1):63. PubMed ID: 27229850
[TBL] [Abstract][Full Text] [Related]
13. Fluticasone, Azithromycin, and Montelukast Treatment for New-Onset Bronchiolitis Obliterans Syndrome after Hematopoietic Cell Transplantation.
Williams KM; Cheng GS; Pusic I; Jagasia M; Burns L; Ho VT; Pidala J; Palmer J; Johnston L; Mayer S; Chien JW; Jacobsohn DA; Pavletic SZ; Martin PJ; Storer BE; Inamoto Y; Chai X; Flowers MED; Lee SJ
Biol Blood Marrow Transplant; 2016 Apr; 22(4):710-716. PubMed ID: 26475726
[TBL] [Abstract][Full Text] [Related]
14. The efficacy of prophylactic azithromycin on bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation.
Jo KW; Yoon S; Song JW; Shim TS; Lee SW; Lee JS; Kim DY; Lee JH; Lee JH; Choi Y; Lee KH
Int J Hematol; 2015 Sep; 102(3):357-63. PubMed ID: 26121954
[TBL] [Abstract][Full Text] [Related]
15. A call to arms: a critical need for interventions to limit pulmonary toxicity in the stem cell transplantation patient population.
Radhakrishnan SV; Hildebrandt GC
Curr Hematol Malig Rep; 2015 Mar; 10(1):8-17. PubMed ID: 25662904
[TBL] [Abstract][Full Text] [Related]
16. Bronchiolitis obliterans syndrome after allogeneic hematopoietic SCT: phenotypes and prognosis.
Bergeron A; Godet C; Chevret S; Lorillon G; Peffault de Latour R; de Revel T; Robin M; Ribaud P; Socié G; Tazi A
Bone Marrow Transplant; 2013 Jun; 48(6):819-24. PubMed ID: 23208317
[TBL] [Abstract][Full Text] [Related]
17. Soluble tumor necrosis factor receptor: enbrel (etanercept) for subacute pulmonary dysfunction following allogeneic stem cell transplantation.
Yanik GA; Mineishi S; Levine JE; Kitko CL; White ES; Vander Lugt MT; Harris AC; Braun T; Cooke KR
Biol Blood Marrow Transplant; 2012 Jul; 18(7):1044-54. PubMed ID: 22155140
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis and treatment of pulmonary chronic GVHD: report from the consensus conference on clinical practice in chronic GVHD.
Hildebrandt GC; Fazekas T; Lawitschka A; Bertz H; Greinix H; Halter J; Pavletic SZ; Holler E; Wolff D
Bone Marrow Transplant; 2011 Oct; 46(10):1283-95. PubMed ID: 21441964
[TBL] [Abstract][Full Text] [Related]
19. Fluticasone, azithromycin and montelukast therapy in reducing corticosteroid exposure in bronchiolitis obliterans syndrome after allogeneic hematopoietic SCT: a case series of eight patients.
Norman BC; Jacobsohn DA; Williams KM; Au BK; Au MA; Lee SJ; Moravec CK; Chien JW
Bone Marrow Transplant; 2011 Oct; 46(10):1369-73. PubMed ID: 21132024
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
